Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saquinavir/ritonavir vs atazanavir/ritonavir lipid profile study in first-line HIV-1 treatment
2006-000666-37Phase 4Completed
- Sponsor
- IATEC
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of saquinavir, atazanavir, ritonavir, tenofovir disoproxil fumarate and emtricitabine in Human immunodeficiency virus infection type 1 (2 arms), sponsored by IATEC. Primary endpoints: Difference in change in total cholesterol at 24 weeks, Difference in change in triglycerides at 24 weeks and 2 more. Started May 2006; status: completed.
02
Drugs
saquinaviratazanavirritonavirtenofovir disoproxil fumarateemtricitabine
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2006-000666-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000666-37.